Summit Trail Advisors’s Tenet Healthcare THC Stock Holding History

Summit Trail Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.7M	Sell	9,109 -269	-3%	-$49.5K	0.02%	705
2026 Q1	$1.77M	Buy	9,378 +1,704	+22%	+$359K	0.03%	619
2025 Q4	$1.52M	Buy	7,674 +255	+3%	+$51.5K	0.03%	577
2025 Q3	$1.51M	Buy	7,419 +1,551	+26%	+$275K	0.02%	602
2025 Q2	$1.03M	Buy	5,868 +2,955	+101%	+$445K	0.02%	467
2025 Q1	$392K	Buy	2,913 +940	+48%	+$124K	0.01%	279
2024 Q4	$249K	Buy	1,973 +65	+3%	+$9.66K	0.01%	328
2024 Q3	$317K	Buy	+1,908	New	+$289K	0.01%	528
2018 Q1	–	Sell	-32	Closed	-$1K	–	1532
2017 Q4	$1K	Buy	+32	New	+$450	﹤0.01%	1869

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Summit Trail Advisors's THC Position: Q2 2026 in Review

Summit Trail Advisors reduced its Tenet Healthcare (THC) stake by 2.9% in Q2 2026, selling an estimated $49.5K and leaving 9,109 shares worth $1.7M. The position accounts for 0.02% of the portfolio, ranked #705.

Summit Trail Advisors first reported a position in THC in Q4 2017 and has held it in 9 quarters since. The position peaked at $1.77M in Q1 2026. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Summit Trail Advisors held 9,109 shares of Tenet Healthcare worth $1.7M as of Q2 2026.
Summit Trail Advisors sold 269 Tenet Healthcare shares in Q2 2026, an estimated $49.5K.
Tenet Healthcare made up 0.02% of Summit Trail Advisors's portfolio in Q2 2026, its #705 holding.
Summit Trail Advisors first reported a position in Tenet Healthcare in Q4 2017 and has held it in 9 quarters since.
Summit Trail Advisors's Tenet Healthcare position peaked at $1.77M in Q1 2026.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.